voda schreef op 15 juli 2022 08:10:
Approval of exsig™ COVID-19 Direct test in the UK under CTDA legislation
in Board, News, Novacyt Group, Uncategorized
Paris, France and Camberley, UK – 15 July 2022 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that the Company’s exsig™ COVID-19 Direct Real-Time PCR test has been approved in the UK under the UK Health Security Agency’s Medical Devices (Coronavirus Test Device Approvals) (Amendment) Regulations 2021 (“CTDA”).
Voor meer, zie de link.
novacyt.com/wp-content/uploads/2022/0...